Table 2.

Triple negative breast cancer patient and CTC characteristics.

Cohort size, age, and disease presentation
Number of patients	12
Number of blood samples per patient, median (range)	1 (1–3)
Age at baseline, median (range), years	43 (39–75)
Germ-line BRCA
Wild type	1
Mutated	4
Unknown	7
Stage of disease
Early	4
Metastatic	5
No evidence of disease	3
CTC detection
Overall number of collected CTCs	42
Number per patient, median (range)	3 (1–10)
Number of sequenced CTCs	35
Timing of collection of sequenced CTCs
During treatment	13
Follow-up	4
At relapse	18